TNFRSF8 and anaplastic large cell lymphoma: The presence of increased levels of soluble CD30 in the plasma of patients with HL and ALCL could raise concerns about competitive CAR binding; however, in vitro studies demonstrated that it did not negatively impact the activity of anti-CD30 CAR-Ts [146, 150].